AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1791-2431|34|1|33-42

ISSN： 1021-335X

Source： Oncology Reports, Vol.34, Iss.1, 2015-01, pp. : 33-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways

By                    

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 203-210

Spandidos Publications

Access to resources Recommend Favorite

AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent

By Cashen Amanda F   Nervi Bruno   DiPersio John  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 19-27

Future Medicine

Access to resources Recommend Favorite

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells

By Yoshida D.   Koketshu K   Nomura R.   Teramoto A.  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 51-64

Springer Publishing Company

Access to resources Recommend Favorite

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

By Lin Feng  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 649-653

Humana Press, Inc

Access to resources Recommend Favorite

NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways

By              

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2011-2021

Spandidos Publications

Access to resources Recommend Favorite